NRDL+ Executive Debrief

The NRDL+ Executive Debrief is specifically crafted to bridge the gap in English-language resources on China's innovative medicine access landscape. It's your key to staying updated on access policy developments, providing you with a competitive edge by fostering a holistic and nuanced understanding of the Chinese innovative medicine market.

Stay abreast of access policy developments in minutes.

We comb hundreds of Chinese and English websites and other publicly accessible sources to monitor, capture, and dissect policy developments that impact pricing, payment mechanisms, and healthcare delivery channels for innovative medicines in China. We then present the information to you in a concise, easy-to-read PowerPoint format.

Connect the dots for a competitive edge.

Our debrief goes beyond surface-level analysis to illuminate the hidden intricacies of the Chinese market. Serving as both an educational tool and a strategic compass, we delve deep into our analysis to connect the dots, providing a holistic and nuanced market understanding rarely found in English media.

Foster a balanced view to preserve the rights to win in China.

We strive to offer a balanced perspective in our analyses, which is essential for assessing opportunities and risks in China amidst increasingly complex geopolitical dynamics. By offering a balanced view, we equip global teams with a common foundation for strategic decision-making.

What does the Executive Debrief tier include?


πŸ’‘
Weekly bulletins summarizing recent developments affecting pricing and access to innovative medicines in China.
πŸ’‘
Full access to deep-dive analyses that dissect access policies impacting pricing, payment mechanisms, and healthcare delivery channels for innovative medicines in China, providing you with a holistic and nuanced understanding of the Chinese market rarely found in English media.
πŸ’‘
Monthly debriefings distill recent access policy signals to help you stay ahead of the curve.
πŸ’‘
Annual executive debriefs and companion live webinars condense policy trends and main themes, delving into key implications drawn from developments over the past year.
πŸ’‘
Ad-hoc live webinars on emerging hot topics tailored to member interests.
πŸ’‘
Full access to archives from past years.

What does the Debrief Professional tier include?


The Debrief Professional tier presents an excellent opportunity for global teams to remain abreast of access policy developments and foster a deeper grasp of the Chinese innovative medicine market.

Professional tier members will enjoy full access to weekly bulletins and deep-dive articles that dissect access policies impacting pricing, payment mechanisms, and healthcare delivery channels for innovative medicines.


Frequently Asked Questions

Who is the Debrief for?

The debrief caters to decision-makers and global teams who aim to stay informed about China's evolving access landscape for innovative medicines. These folks may include, but are not limited to, the following:

  • Global commercial and access leaders aspiring to enhance market performance and access strategies for innovative medicines in China
  • Policy heads focused on improving China's policy environment for innovative medicines
  • Product development executives assessing strategies for innovative portfolios in the Chinese market and globally
  • Business development and investment professionals aiming to optimize investments and partnerships in China

What the Debrief does NOT cover?

It's important to note that the Debrief does not serve as a step-by-step how-to guide for implementation, nor does it furnish assistance for decisions at the product level.

What happens if I cannot make a live webinar?

The sessions will be recorded. But for the best experiences, it would be wonderful to have you on the call to participate firsthand.

Could you provide pricing details for multi-user licenses?

Thank you for your inquiry! Teams can unlock significant savings with our multi-license discounts. The more users you have, the lower the cost per user becomes. All annual subscription rates are listed in US dollars and include taxes.

Executive Debrief:

1 user: $6,450
2-5 users: $3,870 per user
6-12 users: $1,843 per user
12+ users: custom

For instance, if you have 2 users, the total annual fee would be $10,320. If you have 6 users, the total annual fee would be $23,773, calculated as $6,450 (for 1 user) + $3,870 multiplied by 4 (for 4 additional users) + $1,843 (for the remaining user).

Debrief Professional:

1 user: $3,225
2-5 Users: $1,935
6-12 users: $921
12+ users: custom

For further details, including payment options and enrollment instructions, please send us a message indicating the number of licenses you require.

Is there a free trial available?

Yes. We offer a one-month complimentary trial to teams interested in evaluating our executive-tier programming. For team free trials, each company may select two representatives to participate.

For further details, please fill out our free trial request form. We will reach back out to you shortly.

What’s the refund policy?

Regrettably, we do not provide refunds. However, you may submit a replacement if your company has any personnel-related changes.

How do I cancel my subscription?

Single-license users may cancel their subscriptions anytime online. Cancellation methods for team subscriptions will vary depending on their chosen payment methods.